Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY – Research Report), Blueprint Medicines (BPMC – Research Report) and Medtronic (MDT – Research Report).
Alnylam Pharma (ALNY)
In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Alnylam Pharma, with a price target of $246.00. The company’s shares closed last Thursday at $147.43, close to its 52-week low of $143.52.
According to TipRanks.com, Ahmad is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alnylam Pharma with a $221.16 average price target, representing a 47.4% upside. In a report issued on February 8, Canaccord Genuity also maintained a Buy rating on the stock with a $284.00 price target.
See today’s best-performing stocks on TipRanks >>
Blueprint Medicines (BPMC)
Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines yesterday and set a price target of $70.00. The company’s shares closed last Thursday at $87.57, close to its 52-week high of $94.00.
According to TipRanks.com, Lawson is a 4-star analyst with an average return of
Blueprint Medicines has an analyst consensus of Moderate Buy, with a price target consensus of $94.92.
Medtronic (MDT)
Barclays analyst Matt Miksic reiterated a Buy rating on Medtronic today and set a price target of $104.00. The company’s shares closed last Thursday at $84.72.
According to TipRanks.com, Miksic is a 5-star analyst with an average return of
Medtronic has an analyst consensus of Moderate Buy, with a price target consensus of $90.25, implying a 7.7% upside from current levels. In a report issued on February 13, Bank of America Securities also maintained a Buy rating on the stock with a $100.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALNY:
